Expression and mutational analysis of TGF-β/Smads signaling in human cervical cancers

Journal of Gynecologic Oncology

Volumn 20, Issue 2, 2009, Pages 117-121

  Ki, Kyung Do ^a   Tong, Seo Yun ^a   Huh, Chu Yeop ^a   Lee, Jong Min ^a   Lee, Seon Kyung ^a   Chi, Sung Gil ^b  

^a Kyung Hee University College of Medicine   (South Korea)

^b Korea University   (South Korea)

Author keywords

Cervical cancer; Expression; TGF Smads

Indexed keywords

MESSENGER RNA; SMAD2 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA1 RECEPTOR TYPE II; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENOMICS; HUMAN; HUMAN TISSUE; MUTATIONAL ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR GROWTH; UTERINE CERVIX CARCINOMA;

EID: 77953366381     PISSN: 20050380     EISSN: 20050399     Source Type: Journal    
DOI: 10.3802/jgo.2009.20.2.117     Document Type: Article

References (20)

1. Shin HR, Jung KW, Won YJ, Park JG; 139 KCCR-affiliated Hospitals. 2002 annual report of the Korea central cancer registry: based on registered data from 139 hospitals. Cancer Res Treat 2004; 36: 103-114
2. Waggoner SE. Cervical cancer. Lancet 2003; 361: 2217-2225
3. Kang SH, Won K, Chung HW, Jong HS, Song YS, Kim SJ, et al. Genetic integrity of transforming growth factor beta (TGF-beta) receptors in cervical carcinoma cell lines: loss of growth sensitivity but conserved transcriptional response to TGF-beta. Int J Cancer 1998; 77: 620-625 (Pubitemid 28340912)
4. Kim JW, Kim HS, Kim IK, Kim MR, Cho EY, Kim HK et al. Transforming growth factor-β1 induces apoptosis through down-regulation of c-mycGene and overexpression of p27Kip1 protein in cervical carcinoma. Gynecol Oncol 1998; 69: 230-236 (Pubitemid 28289965)
5. Shi Y, Massagu J. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 2003; 113: 685-700. (Pubitemid 36724933)
6. Massague J. TGF-beta signal transduction. Annu Rev Biochem 1998; 67: 753-791
7. Pasche B. Role of transforming growth factor beta in cancer. J Cell Physiol 2001; 186: 153-168 (Pubitemid 32041875)
8. Liu X, Sun Y, Weinberg RA, Lodish HF. Ski/Sno and TGF-beta signaling. Cytokine Growth Factor Rev 2001; 12: 1-8.
9. Massague J. How cells read TGF-beta signals. Nat Rev Mol Cell Biol 2000; 1: 169-178
10. Massague J, Chen YG. Controlling TGF-beta signaling. Genes Dev 2000; 14: 627-644
11. Lynch MA, Nakashima R, Song H, DeGroff VL, Wang D, Enomoto T, et al. Mutational analysis of the transforming growth factor beta receptor type II gene in human ovarian carcinoma. Cancer Res 1998; 58: 4227-4232 (Pubitemid 28450015)
12. Kim SJ, Im YH, Markowitz SD, Bang YJ. Molecular mechanisms of inactivation of TGF-beta receptors during carcinogenesis. Cytokine Growth Factor Rev 2000; 11: 159-168 (Pubitemid 30169736)
13. Chen T, Triplett J, Dehner B, Hurst B, Colligan B, Pemberton J, et al. Transforming growth factor-beta receptor type I gene is frequently mutated in ovarian carcinomas. Cancer Res 2001; 61: 4679-4682 (Pubitemid 32691875)
14. Riggins GJ, Kinzler KW, Vogelstein B, Thiagalingam S. Frequency of Smad gene mutations in human cancers. Cancer Res 1997; 57: 2578-2580 (Pubitemid 27283760)
15. Siegel PM, Massague J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer 2003; 3: 807-821 (Pubitemid 37376979)
16. Derynck R, Akhurst RJ, Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 2001; 29: 117-129 (Pubitemid 32952643)
17. Kang SH, Bang YJ, Im YH, Yang HK, Lee DA, Lee HY, et al. Transcriptional repression of the transforming growth factor-beta type I receptor gene by DNA methylation results in the development of TGF-beta resistance in human gastric cancer. Oncogene 1999; 18: 7280-7286 (Pubitemid 30032107)
18. Markowitz SD, Roberts AB. Tumor suppressor activity of the TGF-beta pathway in human cancers. Cytokine Growth Factor Rev 1996; 7: 93-102. (Pubitemid 27202668)
19. Hazelbag S, Kenter GG, Gorter A, Dreef EJ, Koopman LA, Violette SM, et al. Overexpression of the alpha v beta 6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival. J Pathol 2007; 212: 316-324 (Pubitemid 47010065)
20. Welch DR, Fabra A, Nakajima M. Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and meta-static potential. Proc Natl Acad Sci USA 1990; 87: 7678-7682 (Pubitemid 20341780)